“Currently, 35 to 40 hospitals across the country have joined hands with ImmunoACT for CAR-T cell therapy,” said Professor Rahul Purwar, Founder and CEO Chairman of IIT Bombay-incubated company.
“Currently, 35 to 40 hospitals across the country have joined hands with ImmunoACT for CAR-T cell therapy,” said Professor Rahul Purwar, Founder and CEO Chairman of IIT Bombay-incubated company.
Genotype test inadequate for diagnosis of sickling status — IMDA vanguardngr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vanguardngr.com Daily Mail and Mail on Sunday newspapers.
Genotype test inadequate for diagnosis of sickling status — IMDA vanguardngr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vanguardngr.com Daily Mail and Mail on Sunday newspapers.